Adult acute myeloid leukemia with T(16;16)(P13.1;Q22); CBFB-MYH11

Clinical trials for Adult acute myeloid leukemia with T(16;16)(P13.1;Q22); CBFB-MYH11 explained in plain language.

Never miss a new study

Get alerted when new Adult acute myeloid leukemia with T(16;16)(P13.1;Q22); CBFB-MYH11 trials appear

Sign up with your email to follow new studies for Adult acute myeloid leukemia with T(16;16)(P13.1;Q22); CBFB-MYH11, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 1 Completed 2

New combo therapy shows promise for older leukemia patients

Disease control Ongoing

This study tested a combination of two drugs, azacitidine and gemtuzumab ozogamicin, in 133 older adults (age 60+) with untreated acute myeloid leukemia. The goal was to see how well the treatment could put the cancer into remission and improve survival. The approach uses chemoth…

Matched conditions: ADULT ACUTE MYELOID LEUKEMIA WITH T(16;16)(P13.1;Q22); CBFB-MYH11

Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Jul 03, 2026 00:00 UTC

Adult acute myeloid leukemia with T(16;16)(P13.1;Q22); CBFB-MYH11

Get alerted when new Adult acute myeloid leukemia with T(16;16)(P13.1;Q22); CBFB-MYH11 trials appear

New combo therapy shows promise for older leukemia patients